ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2937

Genetic Variants in HLA-C and Class I Pathway Genes Influence Susceptibility to Kawasaki Disease

Chisato Shimizu1, Jihoon Kim2, Hariklia Eleftherohorinou3, Victoria Wright3, Long Hoang4, Adriana Tremoulet5, Alessandra Franco6, Martin Hibberd4, Atsushi Takahashi7,8, Michiaki Kubo9, Kaoru Ito10, Toshihiro Tanaka10,11, Yoshihiro Onouchi10,12, Lachlan Coin3, Michael Levin3, Jane Burns13 and Hiroko Shike14, 1Pediatrics, University of California San Diego, School of Medicine, La Jolla, CA, 2Medicine, University California San Diego, School of Medicine, Division of Biomedical Informatics, La Jolla, CA, 3Imperial College London, London, United Kingdom, 4Genome Institute of Singapore, Singapore, Singapore, 5Pediatrics, University California San Diego, School of Medicine, La Jolla, CA, 6Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, 7Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 8Department of Genomic Medicine, National Cerebral And Cardiovascular Center, Suita, Japan, 9RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 10Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 11Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo, Japan, 12Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan, 13Pediatrics, University California San DIego, School of Medicine, San Diego, CA, 14Penn State Hershey Medical Center, Hershey, PA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, genetics, Kawasaki disease, pediatrics and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Vasculitis III: Pathogenesis

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose:

Host genetics influence susceptibility to Kawasaki disease (KD), an acute pediatric vasculitis, and genome wide association studies (GWAS) have detected variants with modest effects on disease susceptibility. Recently we performed a pathway analysis using a European descent KD GWAS dataset. We reported that the antigen processing and presentation pathway was one of the top 50 pathways associated with KD susceptibility with 9 single nucleotide variants (SNVs) located near HLA-B and C in the HLA class I region driving the association. We speculated that these SNVs in the HLA class I region influence antigen presentation and KD susceptibility.

Methods:

Nine SNVs in the HLA region from our European descent GWAS were tested for association with KD using a Japanese GWAS dataset. To explore the influence of these SNVs on KD susceptibility, we performed expression quantitative trait loci (eQTL) analysis using a US multi-ethnic cohort (n=146) and analyzed the associated polymorphic amino acid sequence of HLA-B and –C by HLA typing an independent U.S. multi-ethnic cohort (n=78) and a Japanese cohort (subset of Japanese GWAS n=275).

Results:

Two SNVs (rs6906846 upstream of HLA-C and rs2254556 upstream of HLA-B) were significantly associated with KD susceptibility in both the European descent and Japanese GWAS datasets (combined nominal p=1.0xE-04 for rs6906846 and p=7.0xE-05 for rs2254556). HLA typing in both our U.S. multi-ethnic cohort (n=78) and the Japanese cohort (n=275) revealed association of the risk allele at this locus with specific HLA-C types (e.g. HLA-C*07:02 U.S. and Japanese combined p=2.8xE-30) and with specific amino acid sequences at multiple HLA-C positions, including several in the peptide binding groove that could influence peptide binding and presentation. The risk allele (A) at rs6906846 was associated with higher expression of HLA-C by microarray (n=146, AA vs. GG p<1.0xE-04) and targeted amplification of whole blood RNA in an independent U.S. multi-ethnic cohort (n=42, AA vs. GG p<5.0xE-02). We extended the eQTL analysis using our U.S. multi-ethnic array data (n=146) to 5 previously reported SNVs associated with KD that were located in/near genes in the HLA class I pathway from the Japanese GWAS: rs2854251 (proximal to antigen peptide transporter (TAP) 1/2 and proteasome subunit beta (PSMB) 8/9) and a Taiwanese GWAS: rs149481 (Endoplasmic reticulum aminopeptidase (ERAP)1/2 region), and rs1873668, rs4243399, and rs16849083 (coatomer protein complex subunit beta 2 (COPB2) region). In our U.S. multi-ethnic cohort (n=146), we found increased transcript levels of TAP2 (GG vs. AA p<5.0xE-03) and PSMB8 (GG vs. AA p<5.0xE-02), and reduced ERAP2 transcripts (AA vs. AC p<5.0xE-03) associated with the corresponding risk alleles.

Conclusion: SNVs that influence the amino acid sequence in the HLA peptide binding groove and that serve as eQTL for HLA-C pathway proteins influence KD susceptibility in diverse ethnic groups. These findings suggest the importance of HLA-C antigen presentation to CD8+ T cells and/or NK cell regulation in KD pathogenesis.


Disclosure: C. Shimizu, None; J. Kim, None; H. Eleftherohorinou, None; V. Wright, None; L. Hoang, None; A. Tremoulet, None; A. Franco, None; M. Hibberd, None; A. Takahashi, None; M. Kubo, None; K. Ito, None; T. Tanaka, None; Y. Onouchi, None; L. Coin, None; M. Levin, None; J. Burns, None; H. Shike, None.

To cite this abstract in AMA style:

Shimizu C, Kim J, Eleftherohorinou H, Wright V, Hoang L, Tremoulet A, Franco A, Hibberd M, Takahashi A, Kubo M, Ito K, Tanaka T, Onouchi Y, Coin L, Levin M, Burns J, Shike H. Genetic Variants in HLA-C and Class I Pathway Genes Influence Susceptibility to Kawasaki Disease [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/genetic-variants-in-hla-c-and-class-i-pathway-genes-influence-susceptibility-to-kawasaki-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-variants-in-hla-c-and-class-i-pathway-genes-influence-susceptibility-to-kawasaki-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology